Profusa (PFSA) Operating Income (2022 - 2026)
Profusa's (PFSA) quarterly Operating Income came in at -$2.5 million in Q2 2026, down 153.74% on a YoY basis from $4.7 million in Q2 2025, and up 36.47% quarter-over-quarter from -$4.0 million in Q1 2026.
Analysis
Profusa (PFSA) Operating Income (2022 - 2026) Analysis & Trends
Profusa (PFSA) has reported Operating Income for 5 consecutive years, with -$2.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Income fell 153.74% year-over-year to -$2.5 million; the trailing twelve-month figure through Jun 2026 stood at -$31.8 million (down 590.16% YoY), and the FY2025 full-year result was -$27.7 million, down 515.69% from the prior year.
- Operating Income rose to -$2.5 million in Q2 2026 per PFSA's latest filing, from -$4.0 million in the prior quarter.
- Across five years, Operating Income topped out at -$217525.0 in Q2 2022 and bottomed at -$21.7 million in Q3 2025.
- Historically, Operating Income has averaged -$2.2 million across 5 years, with a median of -$465499.5 in 2023.
- The sharpest annual moves came in 2023 and 2025: Operating Income gained 28.27% in 2023, then sank 1868.18% in 2025.
- Over 5 years, Operating Income stood at -$407008.0 in 2022, then dropped by 13.06% to -$460158.0 in 2023, then plunged by 135.14% to -$1.1 million in 2024, then tumbled by 229.94% to -$3.6 million in 2025, then gained by 28.71% to -$2.5 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$2.5 million, -$4.0 million, and -$3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Profusa | 141,502.29 | -577,497.71 | - | -2.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.55 Mn |
| Mar 31, 2026 | -4.01 Mn |
| Dec 31, 2025 | -3.57 Mn |
| Sep 30, 2025 | -21.71 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -1.10 Mn |
| Jun 30, 2024 | -253,130.00 |
| Mar 31, 2024 | -470,841.00 |
| Dec 31, 2023 | -460,158.00 |
| Sep 30, 2023 | -290,098.00 |
| Jun 30, 2023 | -314,710.00 |
| Mar 31, 2023 | -443,717.00 |
| Dec 31, 2022 | -407,008.00 |
| Sep 30, 2022 | -404,425.00 |
| Jun 30, 2022 | -217,525.00 |
| Mar 31, 2022 | -241,596.00 |